AzTrials
AzTrials

Ventilatory Performances of Athletes During the Use of the Intra-oral ProtectionsNUPPIANCT05866835

Validation of a Digitalised Intraoral Protection

A study testing Manufacture of custom-made IOP, Ventilation tests and Evaluation of comfort level: in people with Ventilatory Performances of Athletes During the Use of the Intra-oral Protections, run by University Hospital, Bordeaux at 3 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Type III (custom-made) intra-oral protection (IOP) models represent 13% of IOP worn by amateur rugby club players in France. However, this model is recognized as the most effective when made in accordance with essential health and safety requirements. Read more about this study

Who is it for?
Ages 16 to 35 yearsHealthy volunteers can take part
What is being tested?
Manufacture of custom-made IOP, Ventilation tests and Evaluation of comfort level:
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
3 sitesFrance
Study dates
10 Oct 2023to Jan 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Subjects between the ages of 16 and 35,
  • Subject affiliated to a social security system,
  • Subject affiliated with the French Federation of Boxing or Rugby or Football
  • Subject having signed a consent form
  • For minors, legal guardians having signed the free and informed consent form

Who cannot join

  • Subject with a pathology incompatible with the realization of the trial:
  • Absolute contraindications: Recent infarction (wait 5 to 12 days depending on severity), Threat syndrome (lawful test after stabilization - at least 3 days without spontaneous seizures), Resting BP > 200/120 mmHg, Uncompensated heart failure, Third-degree Atrioventricular block, Myocarditis, Pericarditis, Endocarditis, Aortic Dissection, Intracardiac tumor or thrombus, Deep venous thrombosis, Pulmonary Embolism,
  • Relative contraindications: Aortic stenosis (formal contraindication if lipothymia, syncope or signs of heart failure), Severe non-revascularized coronary artery disease, Pulmonary arterial hypertension (formal contraindication if primary), Severe rapid ventricular or supraventricular arrhythmias
  • Subject under B-mimetic drug treatment,
  • Subject with decaying teeth,
  • Subject under court protection,
  • Subject participating in another research study,
  • Subject in pregnancy.

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Philippe POISSON, Dr contact

0557656590

philippe.poisson@chu-bordeaux.fr

France3 sites, 3 recruiting
  • CHU de Bordeaux

    Bordeaux

    Philippe POISSON, Dr, philippe.poisson@chu-bordeaux.fr

    Not yet recruiting
  • CREPS de Bordeaux

    Bordeaux

    Serge LISE, Dr, serge.lise@creps-bordeaux.fr

    Recruiting
  • Institut national du sport, de l'expertise et de la performance (INSEP)

    Paris

    Sébastien LE GARREC, Dr, sebastien.legarrec@insep.fr

    Not yet recruiting

Other trials in France

About this study

Official title: Validation of a Generic Procedure for the Fabrication of a Custom-made Intra-oral Protection Using an Inter-arch Piece

Type III (custom-made) intra-oral protection (IOP) models represent 13% of IOP worn by amateur rugby club players in France.

However, this model is recognized as the most effective when made in accordance with essential health and safety requirements.

Read more

This observation is at the origin of a new approach that the investigators are proposing with the objective of removing the barriers to access to custom-made IOP. This research is based on the combination of new digital technologies, scanning and 3D printing, to develop a new generation of IOP.

This project aims to show the interest of this new generation of "modified unimaxillary" IOP on the ventilation of the athletes and his/her comfort when he/she evolves with his IOP in place

Read the detailed description

Type III (custom) Intra Oral Protection (IOP) models represent 13% of IOP worn by amateur rugby players in France.

However, this model is recognized as the most effective when made in accordance with essential health and safety requirements.

This under-utilization can be explained by the existence of many barriers to the diffusion of custom-made IOP:

  1. Organizational barrier: long fabrication procedure (minimum 3 sessions) requiring qualified people (dental surgeon, dental technician), trained in the technique of making custom IOP and in essential health and safety criteria.
  2. Financial barrier: high cost with a selling price of 200€ to 300€ per unit.
  3. Technical barriers:
  • Difficulties in making custom-made IOP for athletes who wear fixed braces (brackets and wire),
  • Difficulties in improving the impact energy dissipation capacity without affecting the absorption capacity of the custom-made IOP,
  • Difficulties in individualizing and characterizing the IOP.

This observation is at the origin of a new approach proposed in order to remove the barriers to access to custom IOP. Naturally, this project relies on the combination of new digital technologies, scanning and 3D printing, to develop a new generation IOP with :

  • A simpler and shorter procedure,
  • A target price accepted by athletes,
  • "French Association for Standardization"(AFNOR) standards guaranteed,
  • Compatibility with fixed orthodontic treatments,
  • Ability to develop new protection strategies,
  • Ability to improve the athlete's comfort. Currently, the IOP resulting from these technologies are mainly "unimaxillary", i.e. without engagement of the mandibular dental arch and without ventilation space. In order to comply with the Afnor XP S72-427 standard, the project proposes the fabrication of two models of "modified unimaxillary" IOP that ensure the engagement of the mandibular dental arch and the creation of a ventilation space at two different heights, 4mm and 6mm. This project aims to show the interest of this new generation of "modified unimaxillary" IOP on the athlete's ventilation and his comfort when he evolves with his IOP in place. It is based on a population of men and women, minors and adults, practicing a sport at risk of oral trauma and uses a methodology already proven by the research team.
Being tested
Manufacture of custom-made IOP, Ventilation tests, Evaluation of comfort level:
Keywords
ventilatory performance, athlete, intra-oral protection, protection

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Manufacture of custom-made IOPOther

    Manufacture of custom-made "unimaxillary" and "modified unimaxillary" intra-oral protection (IOP) with vertical dimensions of 4 mm and 6 mm. 3D modeling of a IOP based on:

    • digital recording of the maxillary and mandibular dental arches
    • mandibular wedging performed with an inter-arch piece
    • digital recording of the inter-arch position
  • Ventilation testsOther

    Realization of a ventilation test (VO2max) to determine the Maximum Aerobic Speed (MAS).

    Measurement of ventilatory parameters without IOP and with each IOP :

    • At rest, standing still.
    • During a 4 minute run on a treadmill at 50% of MAS.
    • During a 4-minute run on a treadmill, at a speed corresponding to 70% of MAS
  • Evaluation of comfort level:Other

    Collection from participants (self-questionnaire)

Study groups in NCT05866835
Study groupRoleWhat they receive
AthleteExperimentalhealthy, adult or minor (16 years or older), high-level sportsmen and women, volunteers
Receives: Other: Manufacture of custom-made IOP; Other: Ventilation tests; Other: Evaluation of comfort level:

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ventilatory flow per minute

    The ventilatory flow rate per minute will be measured during the ventilation test

    Measured: 3 weeks (W3) after inclusion (W0)

Secondary outcomes (1)
  1. Confort level

    For the evaluation of the comfort level of wearing the IOP, eleven judgement criteria are proposed and evaluated using a visual analogue scale graduated from 0 (uncomfortable) to 10 (very comfortable): retention, muco-gingival aspect, height of mouth opening, volume of the PIB, nausea, phonation, open mouth ventilation, clenched jaw ventilation, salivation, masticatory muscles, temporomandibular joint.

    Measured: 3 weeks (W3) after inclusion (W0)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2023
  2. Study start10 Oct 2023
  3. Primary completionJan 2026 (estimated)
  4. Study completionJan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
Prospective, multi-center experimental study
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05866835
Sponsor's protocol ID
CHUBX 2022/61
Acronym
NUPPIA
Status last verified
Aug 2025
First submitted
10 May 2023
Last updated
8 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Manufacture of custom-made IOP, Ventilation tests and Evaluation of comfort level: in people with Ventilatory Performances of Athletes During the Use of the Intra-oral Protections, run by University Hospital, Bordeaux at 3 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 8 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Philippe POISSON, Dr (0557656590, philippe.poisson@chu-bordeaux.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ventilatory flow per minute (time frame: 3 weeks (W3) after inclusion (W0)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in